Evidence map›Paper›PMID 28151405›Full record

ArticleJournal of clinical microbiology2017

European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay.

Patrick Braun, Rafael Delgado, Monica Drago, Diana Fanti, Hervé Fleury, Maria Rita Gismondo, Jörg Hofmann, Jacques Izopet, Sebastian Kühn, Alessandra Lombardi and 10 more

Abstract readEvaluation StudyMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Patrick BraunLaboratory Dr. Knechten, Medical Center for HIV and Hepatitis, Aachen, Germany.
Rafael DelgadoMicrobiology Department, Hospital Universitario 12 de Octubre and Insituto de Investigation, Hospital 12 de Octubre (i+12), Madrid, Spain.
Monica DragoClinical Chemistry and Microbiology laboratories, Niguarda Ca' Granda Hospital, Milan, Italy.
Diana FantiClinical Chemistry and Microbiology laboratories, Niguarda Ca' Granda Hospital, Milan, Italy.
Hervé FleuryVirology Department, Hôpital Pellegrin, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France.
Maria Rita GismondoClinical Microbiology, Virology and Bioemergence Diagnosis, L. Sacco University Hospital, Milan, Italy.
Jörg HofmannVirology Department, Labor Berlin, Charité Vivantes GmbH, Berlin, Germany.
Jacques IzopetDepartment of Virology, Federative Institute of Biology, Centre Hospitalier Universitaire Toulouse, Toulouse, France.
Sebastian KühnVirology Department, Labor Berlin, Charité Vivantes GmbH, Berlin, Germany.
Alessandra LombardiClinical Microbiology, Virology and Bioemergence Diagnosis, L. Sacco University Hospital, Milan, Italy.
Maria Angeles MarcosDepartment of Clinical Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Centre for International Health Research Barcelona (CRESIB), Barcelona, Spain.
Karine SaunéDepartment of Virology, Federative Institute of Biology, Centre Hospitalier Universitaire Toulouse, Toulouse, France.
Siobhan O'SheaViapath Analytics, Infection Sciences, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Alfredo Pérez-RivillaMicrobiology Department, Hospital Universitario 12 de Octubre and Insituto de Investigation, Hospital 12 de Octubre (i+12), Madrid, Spain.
John RambleViapath Analytics, Infection Sciences, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Pascale TrimouletVirology Department, Hôpital Pellegrin, Centre Hospitalier Universitaire Bordeaux, Bordeaux, France.
Jordi VilaDepartment of Clinical Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, Centre for International Health Research Barcelona (CRESIB), Barcelona, Spain.ORCID 0000-0002-8025-3926
Duncan WhittakerLaboratory Medicine Building, Northern General Hospital, Sheffield, United Kingdom.
Alain ArtusBeckman Coulter, Immunotech, Marseille, France.
Daniel W RhodesBeckman Coulter, Immunotech, Marseille, France dwrhodes@beckman.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The analytical performance of the Veris HCV Assay for use on the new and fully automated Beckman Coulter DxN Veris Molecular Diagnostics System (DxN Veris System) was evaluated at 10 European virology laboratories. Precision, analytical sensitivity, specificity, and performance with negative samples, linearity, and performance with hepatitis C virus (HCV) genotypes were evaluated. Precision for all sites showed a standard deviation (SD) of 0.22 log

Indexed as

Automation, LaboratoryEuropeHepacivirusHepatitis C, ChronicHumansReal-Time Polymerase Chain ReactionSensitivity and SpecificityViral Loadanalytical performanceautomatedHCVquantitation

Identifiers

PMID28151405
PMCPMC5377846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.